Can I get it?
Yes, if a doctor decides it is right for you. Modafinil is authorised in the EU and can be prescribed after a medical review.

Not in our consultation yet. We're continuously onboarding new specialists — leave your email and we'll notify you, or explore our three active areas.
NOTIFY ME WHEN AVAILABLE
NOT AVAILABLE TODAY
Our licensed doctors currently focus on three areas with solid clinical evidence and a clear EU regulatory framework. We extend the catalogue as specialists join and regulation allows. Modafinil is outside the current scope.
Buying Modafinil online without a valid prescription carries counterfeiting and toxicity risks. Always consult a licensed healthcare professional.
IN PLAIN TERMS
Modafinil is a prescription medicine that helps people stay awake, and it is authorised in EU countries for one purpose only: the excessive daytime sleepiness of narcolepsy, a neurological sleep disorder. In 2011 the European Commission removed its other sleep indications after a safety review, so taking it for shift work, ordinary tiredness, focus or "cognitive enhancement" is off-label — outside anything an EU regulator has approved. It is a genuine medicine; it is simply prescribed by sleep and neurology specialists, not by us. Hi-Doctor treats hair loss, weight management and sexual health, and does not treat sleep disorders.
Modafinil is an authorised medicine in the EU, so a licensed doctor can prescribe it when it is clinically appropriate for you.
Yes, if a doctor decides it is right for you. Modafinil is authorised in the EU and can be prescribed after a medical review.
Our doctors review every option and recommend what fits your history and goals.
Every trial behind Modafinil is listed below with how many people took part and whether the results are peer-reviewed or a company announcement.
Jump to the studiesWHAT WE DO COVER
TREATMENTS
Choose what fits. The journey is identical.
A medical consultation on your weight goal. Treatment if appropriate.
€25/month28-day treatment cycle
Explore weight lossAn absolutely discreet consultation for intimate concerns.
€35 one-offFull refund if not approved
Explore sexual healthMedical assessment and tailored treatment for hair loss.
€15/monthBilled €45 every 90 days
Explore hair growthVERIFIED EVIDENCE
WHAT IT IS
A wakefulness-promoting medicine that acts on the brain systems controlling sleep and alertness; its exact mechanism is still not fully understood.
DEVELOPMENT STAGE
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| US Modafinil in Narcolepsy Multicenter Study (9-week trial) | Adults with narcolepsy and excessive daytime sleepiness | 271 | Read out | — |
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| 200 mg daily | Mean sleep latency on the Maintenance of Wakefulness Test increased by 40% versus placebo | 9 |
| 400 mg daily | Mean sleep latency on the Maintenance of Wakefulness Test increased by 54% versus placebo | 9 |
Everyone in this trial had diagnosed narcolepsy; the result says nothing about ordinary tiredness, shift work, or use for concentration in healthy people.
NAMED SAFETY SIGNALS
After an Article 31 safety review, the CHMP opinion of 18 November 2010 and the European Commission decision of 27 January 2011 restricted modafinil in the EU to narcolepsy only, withdrawing the obstructive sleep apnoea, shift-work sleep disorder and idiopathic hypersomnia indications.
The EU review confirmed a link to rare but life-threatening skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis, with higher risk in children; modafinil is not recommended in children.
The EU review found a link with psychiatric adverse reactions including suicidal thoughts, depression and psychotic episodes.
Associated with raised blood pressure and irregular heartbeat; the EU review advised against use in people with uncontrolled hypertension or arrhythmia.
Modafinil is a molecule frequently searched online; it does not currently fall within Hi-Doctor's clinical scope.
WHAT TO KNOW
Hi-Doctor focuses today on three areas — hair growth, weight management and sexual health — and Modafinil sits outside that scope. We can't review your case for this molecule on the platform.
The doctor reviews your questionnaire, rules out contraindications and explains the available options clearly. If your case is not eligible, the doctor tells you at no extra cost and the €35 one-off consultation fee is refunded.
HOW HI-DOCTOR WORKS
1) You fill in the online medical questionnaire in about 4 minutes.
2) An EU-licensed doctor reviews your case in less than 4 hours on average.
3) If appropriate, the doctor issues a prescription electronic prescription valid at any EU pharmacy under EU Directive 2011/24/EU.
4) You collect the medication at your nearest pharmacy and follow up through the private chat in your account — no WhatsApp, no SMS.
REVIEWED BY HI-DOCTOR LICENSED PHYSICIANS · EDUCATIONAL CONTENT, NOT A SUBSTITUTE FOR A CONSULTATION
HOW IT WORKS · 5 STEPS
From the online consultation to ongoing follow-up — without leaving home.
Answer a 5-minute health questionnaire from home.
A licensed doctor reviews your answers and replies personally.
If not approved, we refund your €35 one-off in full.
Collect it at any EU pharmacy with your e-prescription.
Private chat, 4-week check-in, simple prescription renewal.
NOTIFY ME
We only use your email for this notification. You can opt out at any time.
FREQUENTLY ASKED QUESTIONS
HI-DOCTOR NEWSLETTER
At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.